Search research articles
Contact Us
Filters
Showing results (131-140 of 147) with videos related to
Page
of 15
Sort By:
Journal of the American Heart Association
|
April 21, 2020
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y<sub>12</sub> Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study
Francesco Franchi, Fabiana Rollini, Gabriel Faz, et al.
Journal of the American Heart Association
|
June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial
Connie N Hess, Judith Hsia, Ian A Carroll, et al.
Circulation
|
November 1, 2017
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor-Inhibiting Therapies
Dominick J Angiolillo, Fabiana Rollini, Robert F Storey, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Clinical and Translational Science
|
August 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies
Larisa H Cavallari, Craig R Lee, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics
|
April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation
Cameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology
|
April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE Score
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Nature Reviews. Cardiology
|
June 13, 2022
P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary intervention
Davide Capodanno, Usman Baber, Deepak L Bhatt, et al.
Research Square
|
September 2, 2025
Persistent Tic Disorders Are Associated With 17q12 Duplications
Matthew Halvorsen, Sheng Wang, Tyne Miller-Fleming, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 147) with videos related to
Sort By:
Page
of 15
Journal of the American Heart Association
|
April 21, 2020
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y<sub>12</sub> Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study
Francesco Franchi, Fabiana Rollini, Gabriel Faz, et al.
Journal of the American Heart Association
|
June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial
Connie N Hess, Judith Hsia, Ian A Carroll, et al.
Circulation
|
November 1, 2017
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor-Inhibiting Therapies
Dominick J Angiolillo, Fabiana Rollini, Robert F Storey, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Clinical and Translational Science
|
August 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies
Larisa H Cavallari, Craig R Lee, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics
|
April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation
Cameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology
|
April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE Score
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Nature Reviews. Cardiology
|
June 13, 2022
P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary intervention
Davide Capodanno, Usman Baber, Deepak L Bhatt, et al.
Research Square
|
September 2, 2025
Persistent Tic Disorders Are Associated With 17q12 Duplications
Matthew Halvorsen, Sheng Wang, Tyne Miller-Fleming, et al.
Page
of 15